Dr. Jordan Tsigarides is a Senior Clinical Fellow in Rheumatology (Cambridge University Hospitals) and Doctoral Research Fellow at the University of East Anglia, where he leads research at the intersection of chronic pain, immersive technology and neurotechnology. His work focuses on how virtual reality, eye tracking, wearable sensors and artificial intelligence can support future digital therapeutics in chronic pain. He is also investigating novel EEG biomarkers in chronic pain through collaborations with Kings College London, TwinsUK, University of Cambridge and University of Liverpool.

Jordan originally joined UEA as an Academic Clinical Fellow, during which he established the MSK Therapeutic VR Lab and developed one of the earliest large-scale immersive education programmes within a UK NHS trust. He has produced extensive VR-based educational resources, contributed to curriculum innovation at Norwich Medical School and championed sustainable approaches to technology-enhanced learning. His Masters in Clinical Education included primary research on 360-degree simulation training (The Sim360 Trial), and he continues to support colleagues in embedding immersive methods into teaching and service development.

His doctoral research, VR-FOCUS, investigates closed-loop VR interventions capable of dynamically adapting to physiological and behavioural signals. This builds on previous studies examining VR for chronic pain management and neurobiological signatures underpinning chronic widespread pain (The VIPA Studies). Central to his work is a co-development ethos, involving people with lived experience of pain, clinicians and technologists to ensure interventions are meaningful, acceptable and grounded in real-world symptom variability. This has led to the development of a National Co-development Hub for Digital Technologies in Chronic Pain (Launching in 2026).

Jordan contributes nationally to the evolution of digital and neurotechnological approaches in musculoskeletal and pain research. He is an organiser within  Alan Turing Institute’s Clinical AI Suprainterest Groups (NeuroAI and MSK AI), a member of the British Society for Rheumatology’s AI Special Interest Group, and an active contributor to the MRC Neurotechnology in Chronic Pain Network+ and the NIHR Translational Research Collaboration Pain Workstream, providing expertise spanning AI, immersive therapeutics, wearables and MSK health.

He is regularly invited to speak internationally on VR, digital biomarkers and AI in education and chronic pain. His overarching aim is to advance patient-centred, mechanistically informed approaches to pain assessment and intervention through the responsible integration of state-of-the-art computational and immersive technologies